Table 2 Primary and secondary outcomes of patients in DIRECT-MT

Clinical outcomes

mRS score at 90 days, median(IQR)

3(2–5)

4(2–5)

 mRS of 0–1 at 90 days, n (%)

  0–1

100(23.31)

50(24.15)

  2–6

329(76.69)

157(75.85)

 mRS of 0–2 at 90 days, n (%)

  0–2

166(38.69)

68(32.85)

  3–6

263(61.31)

139(67.15)

 mRS of 0–3 at 90 days, n (%)

  0–3

241(56.18)

98(47.34)

  4–6

188(43.82)

109(52.66)

  NIHSS score after 24 h, median (IQR)

11(4–19)

15(6–26)

  NIHSS score at 5–7 days or discharge, median (IQR)

6.5(2–16)

10(2–23)

  Barthel Index at 90 days, n (%), 95 OR 100

215(50.12)

81(39.13)

Procedural outcomes

 eTICI score assessed on final angiogram, n (%)

  ≥ 2b

340(81.34)

169(83.25)

  < 2b

78(18.66)

34(16.75)

 Total attempts of thrombectomy, median (IQR)

2(1–3)

2(1–3)

 Outcome lesion volume on CT, median (IQR)^a

36.1(9.44,106.40)

38.1(11.33,103.62)

Safety outcomes

 Death, n (%)

73(17.02)

45(21.74)

 Symptomatic intracranial hemorrhage, n (%)^b

25(5.83)

8(3.86)

 Asymptomatic intracranial hemorrhage, n (%)

151(35.20)

77(37.20)

 Infarction in new territory at 5–7 days, n (%)

17(3.96)

3(1.45)

Technical complications

 Any procedural complications, n (%)

68(15.85)

27(13.04)

 Vessel dissection, n (%)

8(1.86)

5(2.42)

 Contrast extravasation, n (%) ^c

14(3.26)

2(0.97)

 Embolization into a new territory, n (%)^d

45(10.49)

20(9.66)